![]() |
市场调查报告书
商品编码
1766117
广角成像系统市场,2032 年全球预测:按组件、模式、技术、应用、最终用户和地区划分Widefield Imaging Systems Market Forecasts to 2032 - Global Analysis By Component (Instruments and Software), Modality, Technology, Application, End User, and By Geography |
根据 Stratistics MRC 的数据,全球广角成像系统市场预计在 2025 年达到 10.6 亿美元,到 2032 年将达到 27 亿美元,预测期内的复合年增长率为 14.3%。
广角成像系统是一种光学仪器,用于在单幅影像中捕捉样本或场景的大面积区域,提供宽广的视野。它们常用于医学成像、天文学和显微镜检查,无需扫描即可对结构或区域进行细緻观察。这些系统能够提高诊断准确性,提升工作流程效率,对于需要即时或静态成像全面覆盖空间的应用至关重要。
根据美国疾病管制与预防中心 (CDC) 的数据,2021 年美国约有 2,970 万人被诊断出患有糖尿病。
眼科疾病盛行率不断上升
在全球范围内,糖尿病视网膜病变、老龄化黄斑部病变和青光眼等眼部疾病的发生率不断上升,大大推动了对宽视野成像系统的需求。由于早期准确的诊断对于有效的疾病管理至关重要,人们越来越依赖先进的视网膜成像技术。这些系统可以清楚地显示週边视网膜,有助于发现传统影像技术经常遗漏的病变。病患和医护人员意识的不断提高也进一步促进了市场扩张。因此,预计全球眼科诊所和医院对宽视野成像系统的采用将稳定成长。
专业技能人才短缺
儘管广角成像系统具有临床效用,但它需要训练有素的专业人员进行精确的影像撷取和解读。许多开发中地区面临着能够有效操作这些设备的眼科技术人员和专业人员的短缺。此外,使用先进成像设备的学习曲线陡峭,也进一步限制了广角成像技术的发展。如果没有充分的培训,对视网膜影像的错误解读可能会导致漏诊。因此,熟练劳动力的短缺是市场成长的主要障碍。
研发活动的成长
广角成像系统市场可望受益于眼科研究和创新领域不断增长的投资。学术机构、研究实验室和产业参与者之间的合作正在推动高解析度、多模态成像技术的发展。远距眼科护理和人工智慧诊断领域的新兴应用正在拓展这些设备的潜在使用案例。政府和私人机构对视觉研究的津贴也刺激了新产品的开发。预计研发活动的激增将在不久的将来为製造商和技术提供者创造丰厚的机会。
资料管理和储存问题
广角成像系统产生的高解析度影像需要庞大的资料储存容量。管理、储存和保护如此大量的信息,对医疗机构而言,带来了技术和后勤方面的挑战。资料隐私问题日益严重,尤其是在医疗资讯监管严格的地区。与电子健康记录(EHR) 系统的整合并非总是无缝衔接,导致临床工作流程效率低。此外,网路安全措施不足也可能导致敏感的患者资料面临潜在的外洩风险。
COVID-19的影响
新冠疫情扰乱了眼科常规诊疗,延误了非紧急诊断程序,并影响了对诊断影像设备的需求。然而,疫情也凸显了对非接触式高效率诊断工具的需求,加速了先进影像处理技术的普及。疫情后的復苏正在推动医疗基础设施和眼科诊断领域的投资恢復。数位化医疗解决方案和远距会诊的兴起,进一步推动了广角影像在远距眼科的应用。
预计软体领域将成为预测期内最大的领域
预计在预测期内,软体领域将占据最大的市场占有率,这得益于数位影像技术的进步、对疾病早期检测需求的不断增长以及慢性眼科疾病率的上升。人工智慧的整合以提高诊断准确性,以及医疗基础设施投资的不断增加将支持市场扩张。这些因素正在推动技术创新,并推动宽视野成像系统在全球临床环境中的广泛应用。
预计在预测期内,医院部门的复合年增长率最高。
在全球范围内,视网膜疾病(尤其是糖尿病视网膜病变和老龄化黄斑部病变)的盛行率不断上升,因此需要早期全面诊断。高解析度、快速成像和人工智慧整合等技术进步显着改善了诊断能力,显着改善了临床工作流程。此外,随着预防保健的日益重视,加上该系统能够在单次曝光中提供广阔的视网膜视野,正在推动高效患者筛检和改善疗效的采用。
预计亚太地区将在预测期内占据最大的市场占有率。该地区人口众多且老化,导致糖尿病视网膜病变等视网膜疾病的发生率很高。医疗保健基础设施的快速改善,尤其是在印度和中国等新兴经济体,正在提高先进诊断工具的可近性。此外,人们对眼部健康的认识不断提高,以及包括人工智慧整合在内的广角成像技术的重大进步,也正在推动市场扩张。
在预测期内,北美预计将呈现最高的复合年增长率,这是由于人口老化和糖尿病盛行率上升导致视网膜疾病(尤其是糖尿病视网膜病变和老龄化黄斑部病变)盛行率高。该地区还受益于先进的医疗基础设施、健全的报销政策以及对疾病早期发现和预防保健的重视。此外,人工智慧的整合和影像品质的提升等快速的技术创新正在加速其应用。
According to Stratistics MRC, the Global Widefield Imaging Systems Market is accounted for $1.06 billion in 2025 and is expected to reach $2.70 billion by 2032 growing at a CAGR of 14.3% during the forecast period. Widefield imaging systems are optical devices used to capture large areas of a sample or scene in a single image, offering a broad field of view. Commonly used in medical imaging, astronomy, and microscopy, they allow for detailed observation of structures or regions without the need for scanning. These systems enhance diagnostic accuracy, improve workflow efficiency, and are essential for applications requiring comprehensive spatial coverage in real-time or static imaging.
According to the Centers for Disease Control and Prevention (CDC), approximately 29.7 million individuals in the U.S. were diagnosed with diabetes in 2021.
Rising prevalence of eye diseases
The increasing global incidence of ophthalmic conditions like diabetic retinopathy, age-related macular degeneration, and glaucoma is significantly boosting demand for widefield imaging systems. Early and accurate diagnosis is crucial for effective disease management, leading to growing reliance on advanced retinal imaging technologies. These systems offer detailed views of the peripheral retina, facilitating the detection of pathologies often missed by traditional imaging methods. Growing awareness among patients and healthcare professionals is further contributing to market expansion. As a result, the adoption of widefield imaging systems is expected to rise steadily in ophthalmology clinics and hospitals worldwide.
Lack of skilled professionals
Despite their clinical utility, widefield imaging systems require trained professionals for accurate image acquisition and interpretation. In many developing regions, there is a shortage of ophthalmic technicians and specialists who can effectively operate these devices. The steep learning curve for handling sophisticated imaging equipment further limits widespread adoption. Without adequate training, misinterpretation of retinal images can lead to diagnostic errors. Consequently, the lack of skilled personnel remains a key barrier to market growth.
Growth in research and development activities
The widefield imaging systems market is poised to benefit from escalating investment in ophthalmic research and innovation. Collaborations between academic institutions, research labs, and industry players are driving the development of high-resolution and multimodal imaging technologies. Emerging applications in teleophthalmology and AI-enabled diagnostics are expanding the potential use cases for these devices. Government and private grants for vision research are also fueling new product development. This surge in R&D activities is expected to create lucrative opportunities for manufacturers and technology providers in the near future.
Data management and storage issues
The high-resolution images generated by widefield imaging systems require substantial data storage capacity. Managing, storing, and securing this volume of information presents technical and logistical challenges for healthcare institutions. Data privacy concerns are heightened, particularly in regions with stringent health information regulations. Integration with electronic health records (EHR) systems is not always seamless, causing inefficiencies in clinical workflows. Moreover, inadequate cybersecurity measures can expose sensitive patient data to potential breaches.
Covid-19 Impact
The COVID-19 pandemic disrupted routine ophthalmic care and delayed non-urgent diagnostic procedures, impacting the demand for imaging devices. However, it also highlighted the need for contactless and efficient diagnostic tools, accelerating the adoption of advanced imaging technologies. Post-pandemic recovery is seeing renewed investments in healthcare infrastructure and ophthalmic diagnostics. The shift toward digital health solutions and remote consultations further supports the use of widefield imaging in teleophthalmology.
The software segment is expected to be the largest during the forecast period
The software segment is expected to account for the largest market share during the forecast period, driven by advancements in digital imaging technology, increasing demand for early disease detection, and the rising prevalence of chronic eye conditions. Integration of artificial intelligence enhances diagnostic accuracy, while growing investments in healthcare infrastructure support market expansion. These drivers collectively fuel innovation and the global uptake of widefield imaging systems across clinical settings.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to the rising global prevalence of retinal diseases, particularly diabetic retinopathy and age-related macular degeneration, necessitates early and comprehensive diagnosis. Technological advancements, including higher resolution, faster imaging, and AI integration for enhanced diagnostics, significantly improve clinical workflows. Additionally, the growing emphasis on preventive healthcare, coupled with the systems' ability to provide wide retinal views in a single capture, drives their adoption for efficient patient screening and improved outcomes.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to the region's large and aging population contributes to a higher incidence of retinal diseases like diabetic retinopathy. Rapidly improving healthcare infrastructure, especially in emerging economies like India and China, increases accessibility to advanced diagnostic tools. Furthermore, growing awareness about eye health and significant technological advancements in widefield imaging, including AI integration, are propelling market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high prevalence of retinal diseases, particularly diabetic retinopathy and age-related macular degeneration, fuelled by an aging population and increasing diabetes rates. The region also benefits from advanced healthcare infrastructure, robust reimbursement policies, and a strong emphasis on early disease detection and preventive care. Furthermore, rapid technological innovations, including AI integration and improved image quality, are accelerating adoption.
Key players in the market
Some of the key players profiled in the Widefield Imaging Systems Market include Optos, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Topcon Corporation, NIDEK Co., Ltd., Canon Inc., Clarity Medical Systems, Inc., Centervue SpA, Forus Health Pvt Ltd., Optomed Oy Ltd., Epipole Ltd., Remidio Innovative Solutions Pvt Ltd., Phoenix Technology Group, LLC., Kowa Company Ltd., and Visunex Medical Systems Inc.
In May 2025, Topcon Healthcare, Inc., announced the acquisition of RetInSight GmbH renowned for its innovation in retinal imaging AI solutions. The move advances Topcon Healthcare's vision of Healthcare from the Eye(TM), enhancing access to intelligent diagnostics that increase access to high-quality eye care, reduce healthcare costs, and improve clinical outcomes.
In April 2025, Canon announced the resolution of patent infringement disputes against Shanghai Sinocopy Industrial Co., Ltd. and Zhongshan Sinocopy Electronic Co., Ltd. Shanghai Sinocopy Industrial Co., Ltd. and Zhongshan Sinocopy Electronic Co., Ltd. are hereinafter collectively referred to as Sinocopy) in Shanghai Intellectual Property Court of China, concerning certain toner cartridges sold for use in various models of HP laser beam printers.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.